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The double-stranded RNA-dependent protein kinase PKR is an interferon-inducible enzyme that possesses antiviral
and antiproliferative activities. We examined expression of PKR transcripts in human placenta tissue and cultured
human amnion U cells. Alternative exon 2 structures were identified and characterized that possess different functional
activities. Cloning and sequence analyses of 59-RACE cDNAs from human placenta established a linkage between exon
1 and three alternative exon 2 structures that constitute, together with part of exon 3, the 59-untranslated region of the
PKR mRNA. The alternative splice variants of exon 2 were designated Ex2a (83 nucleotides), Ex2b (167 nucleotides), and
Ex2g (401 nucleotides). All three exon 2 variants were present in placenta tissue. However, only the Ex2a and Ex2b
forms were detectable in the amnion U cell line. Nuclease protection analysis revealed that the Ex2b form was slightly
more abundant than the Ex2a form, in both placenta tissue and U cells. Interferon treatment of U cells increased the
level of both Ex2a and Ex2b RNA by ;5-fold. The translational activities, measured in a luciferase reporter assay, of
RNA transcripts possessing the Ex2a and Ex2b forms of the PKR 59-UTR were comparable to each other and more
efficient than those with the Ex2g form. © 1999 Academic Press
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(INTRODUCTION
The protein kinase PKR is an interferon (IFN)-inducible
NA-dependent enzyme (Clemens and Elia, 1997; Sam-
el, 1993). Kinase activity is acquired after activation of
KR through autophosphorylation, a process mediated
y double-stranded RNA (Samuel, 1979; Patel et al., 1996;
omano et al., 1998; Thomis and Samuel, 1993). Once
ctivated, PKR catalyzes the phosphorylation of the a
ubunit of eukaryotic protein synthesis initiation factor 2
eIF-2a) on serine 51, a modification that leads to an
nhibition of mRNA translation (Hershey, 1989). Because
f its fundamental biochemical activity, PKR modulates a
ange of biological processes, including virus replication
nd cell growth, differentiation, and death (Clemens and
lia, 1997; Katze, 1995; Samuel, 1991; Sen and Lengyel,
992; Stark et al., 1998).
PKR from human cells is a 551-amino-acid protein as
educed from cDNA clone sequences (Meurs et al.,
990; Thomis et al., 1992). The functional domains of PKR
nclude the kinase catalytic subdomains located in the
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106arboxyl-terminal half of the protein and two copies of
he prototype double-stranded RNA-binding motif
dsRBM) located in the amino-terminal half of the protein
Clemens and Elia, 1997; Kharrat et al., 1995; Samuel,
993). The dsRBM structures bind both activator and
nhibitor RNAs in a sequence-independent fashion (Mc-
ormack et al., 1992; McCormack and Samuel, 1995;
evilacqua et al., 1998). Such RNA binding is believed to
ause a conformational change, affecting the catalytic
omains of the PKR protein (Bischoff and Samuel, 1985;
arpick et al., 1997). Dependent on the specific RNA that
s bound, this process either can lead to autophosphor-
lation and activation or prevent autoactivation of the
KR kinase (Clemens and Elia, 1997; Samuel, 1993).
The Pkr gene spans ;50 kb on human chromosome
p (Kuhen et al., 1996). Induction by IFN of Pkr gene
ranscription is mediated by a TATA-less promoter. At
east two DNA elements are required for optimal Pkr
romoter activity. A single copy of the 13-bp IFN-stimu-
ated response element (ISRE) is responsible for the
nducibility of Pkr transcription (Kuhen and Samuel, 1997;
anaka and Samuel, 1994). A novel 15-bp element des-
gnated KCS for kinase conserved sequence, because it
s exactly conserved in sequence and position between
he human and mouse Pkr promoters (Kuhen and Sam-
el, 1997), is required for optimal Pkr promoter activity
Kuhen and Samuel, 1997; Kuhen et al., 1998). The human
kr gene contains 17 exons (Kuhen et al., 1996). Exons 1
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107SPLICE VARIANTS OF THE HUMAN PKR PROTEIN KINASEnd 2 and part of exon 3 constitute the 59-UTR of the
ajor human PKR transcript, as deduced from sequence
nalysis of independently isolated cDNA clones (Kuhen
t al., 1996, Meurs et al., 1990, Thomis et al., 1992). Exon
includes the AUG translation initiation site as estab-
ished by ribosome protection analysis with the cDNA-
erived transcripts (Thomis et al., 1992). The 59-UTR
equence obtained by the 59-RACE procedure using
DNA prepared with RNA isolated from human placenta
issue revealed the presence of three alternative splice
ariants of exon 2; the 2a isoform was the shortest at 83
ucleotides (nt), 2b was 167 nt, and 2g was the longest
t 401 nt (Kuhen, 1997).
Because the splice variants of exon 2 were identified
n primary placenta tissue in the absence of IFN treat-
ent and because the observed alternative splicing
ithin the intron 1–exon 2 region of PKR pre-mRNA
hanged the structure of the 59-UTR region of the mature
KR mRNA, we considered the possibilities that the exon
splicing pattern either was altered by IFN treatment
nd/or that the three 59-UTR forms of exon 2 differentially
ffected translational activity. In this communication, we
etermine the exon 2 isoform distribution in primary
lacenta tissue compared with cultured amnion U cells,
etermine the effect of IFN treatment on the relative
istribution of exon 2 splice variants in cell culture, and
stablish the effect of altered exon 2 structure on trans-
FIG. 1. Schematic structure of the three alternative splice variants wi
odon (ATG) is located in exon 3. Intron I sequences corresponding to
a-containing Pkr mRNA possesses an 83-bp exon 2 originating at nt 2
t 2183, and exon 2g-containing Pkr mRNA possesses a 401-bp exonational activity in transfected human cells. bRESULTS
lternative splice variants of human Pkr possessing
ifferent 59-untranslated regions
A 59-RACE cDNA library prepared from human pla-
enta RNA (Clontech) was screened by PCR using hu-
an Pkr-specific minus primers and library adapter-spe-
ific plus primers. The 59RACE PCR products obtained
ere subcloned and sequenced. Unexpectedly, three
ifferent classes of products were found that corre-
ponded to alternatively spliced forms of exon 2. Com-
arison of the 59-RACE cDNA sequences with the Pkr
enomic sequence (Kuhen et al., 1996) revealed that
ach class possessed a unique exon 2 sequence: the
9-end of exon 2 terminated at either nt position 2417,
183, or 299, but the 39-end was common for the three
roduct classes and corresponded to nt 217 (Fig. 1). The
7-kb intron I was spliced via a common 59-splice donor
ite and three different 39-splice acceptor sites.
Thirteen individually isolated 59-RACE cDNA clones
ere sequenced. Four were the exon 2a form, seven
ere the exon 2b form, and two were the exon 2g form
hich was least abundant. The 59-ends of the cDNAs
aried and were found to occur independently of the
ature of the exon 2 splice variant form. Four clones
xtended through nt 2435 and these corresponded to
he a form. One clone beginning at nt 2430, two clones
59-untranslated region of the human Pkr mRNA. The translation start
ommon 59 splice site and alternative 39 splice sites are shown. Exon
on 2b-containing Pkr mRNA possesses a 167-bp exon 2 originating at
inating at nt 2417.thin the
the c
99, exeginning at nt 2429, and four clones starting at nt 2422
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108 KAWAKUBO ET AL.ossessed the b form of exon 2. For the two clones
orresponding to the g form, one began at nt 2433 and
he other at nt 2420. The longest version of exon 1
btained by 59-RACE possessed 18 bp. This 59-end of
xon 1 was located 49 nt downstream of the ISRE ele-
ent present in the Pkr promoter previously identified by
ransient transfection and mutagenesis analyses (Kuhen
nd Samuel, 1997).
ifferential expression of the exon 2 a, b, and g
soforms of the human Pkr transcript in placenta
issue and cells in culture
To compare the distribution of the three exon 2 splice
ariants constitutively expressed in human placenta tis-
ue (Fig. 1) with the distribution of exon 2a, b, and g
ariants found in cultured human amnion U cells, RNase
rotection analyses were carried out. RNA isolated from
rimary placenta tissue (Clontech) and RNA isolated
rom U cells not treated with IFN were analyzed. An
ntisense riboprobe (cRNA) complementary to nt 2435
hrough 230 of the human PKR cDNA, corresponding to
xon 1 and most of exon 2g, was used. With the
32P]cRNA probe used, the anticipated protected frag-
ent lengths for the a, b, and g isoforms are 88, 172, and
06 bp, respectively. As shown by the Fig. 2 autoradio-
ram, fragments corresponding to the exon 2a, b, and g
soforms were detected using RNA from human placenta
issue. By contrast, only the a and b isoforms were
etected with RNA from cultured human amnion U cells
hat had not been treated with IFN. An additional Pkr-
pecific exon 2 fragment of ;300 bp was observed with
lacenta RNA but not with RNA from U cells or with
ransfer RNA; the origin is unknown.
The inability to detect the exon 2g isoform by RNase
rotection analysis with RNA from untreated U cells was
nanticipated. Therefore, RNA isolated from the cultured
uman amnion U cells was analyzed by RT and subse-
uent PCR. Only the a and b isoforms of exon 2 were
etected by RT-PCR analysis of RNA isolated from U
ells not treated with IFN (data not shown). Subsequent
loning and sequence analysis of the RT-PCR products
howed that the sequences of the a and b forms of exon
from the human U cell line exactly matched the se-
uences of the exon 2a and 2b isoforms obtained by
9-RACE with RNA from human placenta tissue (Kuhen,
997).
ffect of IFN treatment on the distribution of exon 2
plice variants in U cells
To examine how IFN treatment affected the relative
mount and distribution of the exon 2 splice variant
soforms, RNase protection analyses were performed
ith RNA isolated from human U cells either left un-
reated or treated with IFN-a for 6 h. A representative
utoradiogram showing the results of a nuclease protec- 6ion experiment is shown in Fig. 3A. Both the exon 2a
nd exon 2b isoforms of the Pkr transcript were detected
n U cells, and both forms were increased in amount by
reatment of U cells with IFN-a (Fig. 3A). The exon 2g
soform was not detected by nuclease protection analy-
is with RNA from IFN-treated (Fig. 3A) or untreated
Figs. 2 and 3) U cells.
Quantification of the steady-state levels of Pkr isoform
RNA expression, normalized to the expression level of
-actin mRNA, showed that induction by IFN-a was 5- to
FIG. 2. Expression of the exon 2 alternative splice variants of PKR
RNA in human placenta tissue and the human amnion U cell line.
uclease protection was performed using the 387-nt riboprobe corre-
ponding to the exon 1–exon 2g 59-untranslated region extending from
t 2435 to nt 230 of the human PKR mRNA. Either 10 or 30 mg of total
NA from human placenta tissue (lanes 1 and 2) or from untreated U
ells (lanes 3 and 4) was used for the hybridization. The positions of the
rotected cRNA riboprobe fragments corresponding to exon 2a, 2b,
nd 2g, respectively, are indicated by the filled triangles. Yeast tRNA
as used as a negative control (lane 5); probe alone is shown in lane
. A DNA molecular weight size standard is shown in lane 7.-fold as measured by nuclease protection (Fig. 3B). The
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109SPLICE VARIANTS OF THE HUMAN PKR PROTEIN KINASEelative molar ratio of exon 2a- and exon 2b-containing
KR transcripts was not significantly affected by IFN
reatment. Exon 2b-containing RNA was slightly more
bundant than exon 2a-containing RNA in U cells. The
pparent lack of the exon 2g isoform, even after IFN-a
reatment, further supports the notion that the expression
FIG. 3. IFN treatment of U cells increases the expression of PKR
ranscripts possessing the a and b isoforms of exon 2. (A) RNA isolated
rom untreated (lanes 1 and 3) and IFN-a-treated (6 h) (lanes 2 and 4)
uman U cells, either 10 to 30 mg as indicated, was hybridized with the
87-nt riboprobe corresponding to the exon 1-exon 2g 59-untranslated
egion of human PKR mRNA extending from nt 2435 to nt 230. The
osition of the protected cRNA riboprobe fragments corresponding to
xon 2a and 2b are indicated by the filled triangles. Yeast tRNA was
sed as a negative control (lane 5); probe alone is shown in lane 6.
utoradiography was for 18 h. (B) Quantification of PKR exon 2 isoform
xpression levels using a molecular PhosphorImaging system (Bio-Rad
S525). Expression levels of PKR were normalized to those of b-actin;
he expression level of the PKR exon 2 isoform (2b or 2a) in untreated
cells was assigned a value of 1.0. Protected fragments corresponding
o exons 2a and 2b were standardized for adenine content for molar
atio calculations.f this Pkr transcript variant may be tissue specific. hffect of exon 2 isoform on efficiency of expression
The exon 2b- and 2g-containing transcripts each pos-
ess a common six-amino-acid open reading frame
ORF) initiated by an AUG codon at nt 2138 that con-
orms to a Kozak consensus sequence for translation
nitiation. We considered the possibility that this short
pstream ORF (uORF), or conceivably some other region
f the 59-UTR that differs among the three isoforms,
ight alter the translation of PKR mRNA initiated from the
uthentic downstream AUG initiation codon present in
xon 3 (Thomis et al., 1992). To test whether the exon
–exon 2a, exon 1–exon 2b, and exon 1–exon 2g iso-
orms of the 59-UTR structure differentially affected trans-
ation from the downstream AUG, each 59-UTR variant of
xon 2 linked to the common exon 1 sequence was
nserted 59 to the luciferase reporter gene in the pGL3-
ontrol (Promega) Luc promoter plasmid. This parent
ector, which was used to assess 59-UTR function, pos-
esses both the simian virus (SV) 40 promoter and en-
ancer. The pGL3-Control plasmid vector without in-
erted PKR 59-UTR sequence typically yielded high levels
f luciferase activity in transfected U cells; the luciferase
ctivity of pGL3-Control was assigned a relative value of
00% (Fig. 4). By contrast, as the negative control, the
romoterless pGL3-Enhancer plasmid vector exhibited
ow LUC activity (,2% relative activity).
Human U cells transfected with pGL3-control plasmids
ngineered to include either the a or b isoforms of exon
gave higher luciferase activity than cells transfected
ith the construct that possessed the g isoform of exon
(Fig. 4). The Ex1:Ex2g-pGL3-control reporter plasmid
onsistently gave 2- to 3-fold less luciferase activity com-
ared with cells that were transfected with either the
x1:Ex2a-pGL3-control or the Ex1:Ex2b-pGL3-control re-
orter plasmid. This difference was not affected by IFN
reatment. Transfection with either the Ex1:Ex2a-pGL3-
ontrol or the Ex1:Ex2b-pGL3-control plasmid resulted in
he highest level of expression of the reporter gene, in
oth the presence and the absence of treatment with
FN-a. As controls, the Ex1:Ex2–pGL3-Enhancer con-
tructions that lacked the SV40 promoter showed negli-
ible luciferase activity.
The relative efficiencies of expression of luciferase in
cells transfected with the Ex1:Ex2a-pGL3, Ex1:Ex2b-
GL3, and Ex1:Ex2g-pGL3-control reporter plasmids
ere calculated by measuring the relative steady-state
oncentrations of the luciferase mRNAs and luciferase
nzyme activity in parallel transfected cultures. This
uantification revealed that the efficiency of expression
f luciferase was comparable with the Ex1:Ex2a-pGL3
nd Ex1:Ex2b constructs and ;2-fold higher than that
ith the Ex1:Ex2g-pGL3 construct, in both the untreated
nd IFN-treated cells (Table 1). RNase protection analy-
es performed with RNA isolated from human U cells
ad revealed that the exon 2a and exon 2b isoforms of
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110 KAWAKUBO ET AL.he PKR mRNA were expressed in comparable amounts
nd that both were induced by IFN (Fig. 3B). Similarly, the
teady-state concentrations of luciferase mRNA in cells
FIG. 4. The exon 2g isoform of PKR negatively affects gene expression
lasmids constructed by the insertion of the indicated human PKR 59-un
ossesses both the SV40 promoter and enhancer, or the pGL3-Enhance
xon 1; Ex2, exon 2 a, b, or g splice variant as indicated. (Right) Lucife
ndicated Luc reporter plasmid. Luciferase activity values shown are rel
f 100. To control for transfection efficiency, cells were cotransfecte
eference. Open bars refer to transfected cells that were left untreated
t least three independent transfection experiments.
TABLE 1
Effect of PKR 59-UTR Exon Structure on Efficiency of Expression
PKR 59-UTR LUC
constructa
Relative efficiencyb
Untreated IFN treated
Ex1:Ex2a 1.00c 0.95 6 0.05
Ex1:Ex2b 1.01 6 0.05 1.08 6 0.17
Ex1:Ex2g 0.61 6 0.01 0.60 6 0.11
a Luciferase reporter plasmids possessing the indicated PKR 59-UTR
ere analyzed in human amnion U cells.
b The efficiency of expression is taken as the amount of luciferase
nzyme produced per amount of luciferase template mRNA present. Lu-
iferase enzyme activities were quantified using an OPTOCOMP I lumi-
ometer; cytoplasmic luciferase mRNA amounts were determined in par-
llel by hybridization and quantitated using a Bio-Rad GS525 molecular
hosphorImager. The results are from two independent experiments.
c The relative efficiency of expression of the luciferase mRNA pos-
fessing the PKR exon 1-exon 2a 59-UTR structure is defined as 1.0.ransfected with Ex1:Ex2a-pGL3-control or the Ex1:Ex2b-
GL3-control reporter plasmids possessing 59-UTR
tructures from PKR were comparable to each other and
2.1- and ;1.7-fold higher, respectively, than the con-
entration of luciferase RNA in cells transfected with the
x1:Ex2g-pGL3-control reporter plasmid as determined
y hybridization analysis.
DISCUSSION
Exons 1 and 2 and part of exon 3 of the human Pkr
ene constitute the 59-untranslated region of mRNA en-
oding the kinase (Kuhen et al., 1996). Several important
oints emerge from our results reported herein on the
tructural and functional properties of the PKR 59-UTR.
irst and foremost, multiple forms of the 59-UTR occur,
oth in primary tissue and in cultured cells. The 59-UTR
ncludes three alternative splice variants of exon 2, des-
gnated a, b, and g, each of which is linked in precisely
he same manner to the flanking exons 1 and 3. Second,
ll three of the exon 2 isoforms are found in human
lacenta tissue. However, only the exon 2a and 2b iso-
chematic representation (left) summarizes the luciferase (Luc) reporter
ted region variant isoform into either the pGL3-Control plasmid, which
id, which lacks the SV40 promoter but retains the SV40 enhancer. Ex1,
porter activity observed in human amnion U cells transfected with the
pGL3-Control without PKR 59-UTR insert, which was assigned a value
the pRSV2-b-galactosidase (pRSV2-b-gal) construct as an internal
atched bars refer to cells treated with IFN. SEM was determined from. The s
transla
r plasm
rase re
ative to
d with
, and horms are detectable in human amnion U cells, either
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111SPLICE VARIANTS OF THE HUMAN PKR PROTEIN KINASEntreated or IFN treated. Third, IFN-a treatment of U cells
p-regulates the synthesis of both the a and the b iso-
orms of exon 2. Fourth, the exon 2g isoform displays a
ower activity than either the 2a or 2b isoforms when
xamined in U cells as part of the PKR-derived 59-UTR
ositioned upstream of a reporter protein.
Northern gel-blot analysis of PKR mRNA present in
ntreated and IFN-treated amnion U or Daudi cells
hows a major hybridization signal of ;2.5 kb (Meurs et
l., 1990; Thomis et al., 1992). Presumably, this ;2.5-kb
ranscript seen in human cell lines (Samuel, 1993) largely
epresents PKR mRNAs that possess either the a or b
soforms of exon 2, as they would have a deduced sizes
rom their cDNA sequences of 2.49 and 2.57 kb, respec-
ively. By contrast, the predicted size of PKR transcripts
ossessing the exon 2g splice variant is 2.81 kb, exclud-
ng any contribution from 39-polyadenylation (Fig. 1;
uhen et al., 1996). RNase protection (Fig. 3) and RT-PCR
data not shown) analyses performed with RNA isolated
rom U cells, either untreated or IFN treated, failed to
etect the g isoform of exon 2. Similar to U cells, the a
nd b isoforms, but not the g isoform, of exon 2 are also
resent in constitutively expressed PKR mRNAs of un-
reated Daudi cells (Xu and Williams, 1998). Thus the
esults of nuclease protection, RT-PCR, and Northern
nalyses are consistent with the conclusion that either
xon 2a or exon 2b, but not exon 2g, is present in PKR
ranscripts of cultured human cells. However, both 59-
ACE (Fig. 1) and RNase protection (Fig. 2) analyses
etected the exon 2g splice variant in addition to the
xon 2a and 2b splice variants in human placenta tissue.
hese results suggest that the alternative splicing lead-
ng to the three forms of PKR exon 2 may occur to
iffering extents in different tissues or cells.
The ;2.5-kb PKR transcript is increased ;4- to 5-fold
fter IFN treatment of U cells as measured by Northern
nalysis (Thomis et al., 1992), and the isolated promoter
rom the human Pkr gene shows a ;4- to 5-fold increase
n activity in IFN-treated U cells as measured by a tran-
ient transfection reporter assay (Kuhen and Samuel,
997, Kuhen et al., 1998). Nuclease protection analyses
Fig. 3) established that PKR transcripts possessing the a
nd b isoforms of exon 2 both were induced ;5-fold by
FN treatment of U cells. Furthermore, the ratio of exon
a to exon 2b was similar in untreated and IFN-treated U
ells, whereas exon 2g was not detectable in either
ntreated or IFN-treated U cells (Fig. 3). These results
uggest that IFN treatment does not affect the splicing
attern of PKR transcripts in a manner that alters the
istribution of the alternative splice forms of exon 2, at
east in U cells. This is an important point, because the
NA-specific adenosine deaminase ADAR1 is an IFN-
nducible enzyme (Patterson and Samuel, 1995; George
nd Samuel, 1999). As a C6 adenosine deaminase that
cts on pre-mRNA substrates (Liu and Samuel, 1999; Liu
t al., 1999), ADAR1 has the potential to alter splice site Hunctions. Indeed, the related ADAR2 RNA adenosine
eaminase, which is the product of a different gene and
s not IFN-inducible (Liu and Samuel, unpublished ob-
ervations), is implicated in the regulation of alternative
plicing by catalyzing the deamination an adenosine
esidue essential for splice-site recognition (Reuter et al.,
999).
The two alternative 59-UTR structures of PKR that pos-
ess the a and b forms of exon 2 supported, with com-
arable high efficiency, the expression of a luciferase
eporter in a transfected U cells. Furthermore, the effi-
iency of luciferase expression with plasmid constructs
riven by the SV40 promoter and engineered to possess
9-UTRs with a or b forms of exon 2 was nearly four
imes greater than that with a 59-UTR structure that pos-
essed the g form of exon 2. The difference was in part
ranslational and in part due to differences in the steady
tate amounts of the three isoforms of RNA. About twice
s much luciferase enzyme activity was detected per
mount of luciferase mRNA present in cells transfected
ith the exon 2a and exon 2b constructs than the exon
g construct. And nearly twice as much exon 2a and
xon 2b mRNA accumulated at steady-state than the
xon 2g mRNA. IFN treatment slightly reduced luciferase
xpression in transfected cells, but not the amount of
uciferase enzyme activity produced per unit of luciferase
RNA, consistent with an IFN-induced alteration of
RNA stability. At least two known IFN enzyme path-
ays could conceivably contribute to the IFN induced
eduction. One is the 29,59-oligoadenylate synthetase-
Nase L system (Samuel, 1991; Zhou et al., 1993); the
ther is the inosine-specific RNase functioning in con-
ert with the IFN-inducible ADAR deaminase, which cat-
lyzes the formation of inosine in RNA transcripts (Patter-
on and Samuel, 1995; Scadden and Smith, 1997).
Many eukaryotic mRNAs have a short 59-UTR and lack
UG codons upstream of the authentic translation initi-
tion site. This organization is believed to play an impor-
ant role in those mRNAs whose initiation of translation
s efficient (Kozak, 1992). However, in ;5–10% of verte-
rate mRNAs, the first AUG is not the translational initi-
tion site for the protein-coding ORF (Kozak, 1992). Thus
he nature of the 59-UTR, including length and distribu-
ion of AUG codons upstream of the authentic translation
tart site, can potentially affect the efficiency of transla-
ion. Interestingly, the larger two forms of exon 2, 2b and
g, both possess a common six-amino-acid ORF posi-
ioned at nt 2138 to 2121 (uORF) upstream of the au-
hentic AUG start site for PKR translation. The AUG for
KR initiation is present in exon 3 as deduced from
ibosome protection and mutagenesis experiments (Tho-
is et al., 1992; Kuhen et al., 1996). We considered the
ossibility that this uORF may function to regulate Pkr
ene expression at the level of protein synthesis depen-
ent on the splice variant of exon 2 present in the 59-UTR.
owever, in the case of the PKR 59-UTR, it seems unlikely
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112 KAWAKUBO ET AL.hat the six-amino-acid uORF acts as an attenuator of
KR translation that contributes significantly to the re-
uced expression efficiency observed for transcripts
ossessing exon 2g compared with exon 2a or 2b. The
xon 2b isoform also possesses the six-amino-acid
ORF, and reporter constructs with the alternative exon
b 59-UTR structure are as efficiently expressed as those
ith the alternative exon 2a isoform that lacks the uORF.
The 59-termini of exon 1, determined by 59-RACE and
equencing of 13 RACE cDNA clones, were clustered
ver a 16-nt region. The heterogeneous nature of the
9-end of exon 1 of human PKR may indicate multiple
ifferent transcription initiation sites, as has been ob-
erved for the mouse Pkr gene (Tanaka and Samuel,
994). Alternatively, it is also possible that the hetero-
eneous 59-termini of exon 1 represent incomplete
9-RACE cDNA clones that arise because of the espe-
ially high GC content within this region of the Pkr
ene.
Our finding that the human Pkr mRNA possesses an
dditional exon in the 59-UTR not found in the mouse Pkr
RNA (Kuhen et al., 1996) takes on possible added
ignificance, given that this additional exon found in the
uman gene undergoes alternative splicing to produce
he three alternative exon 2 splice variants characterized
erein. The elucidation of the functional significance of
he different exon 2 splice variants, beyond the differ-
nce in expression efficiency observed with 2a and 2b
ompared with 2g in the transient transfection assay, as
ell as the basis of the difference in alternative exon 2
plicing observed between cell lines and primary tissue
re now of central importance.
MATERIALS AND METHODS
etermination of the 59-cDNA region
The 59-region of the PKR cDNA was obtained by the
9-RACE procedure (Frohman et al., 1988) using the Mar-
thon-Ready cDNA system (Clontech) according to the
anufacturer’s recommendations (Chenchik et al., 1995).
riefly, the 59-end of the PKR cDNA was amplified from
n uncloned library of adaptor ligated cDNA prepared
rom human placenta. First-round PCR was performed
ith a minus primer corresponding to PKR antisense nt
045–1028 (59-CAGGATCATAATCACTGC-39) and the plus
nchor primer AP1 from Clontech. Nested PCR was then
erformed with either one of two additional gene-specific
inus primers corresponding to PKR antisense nt 1177
o 1157 (59-TGATCTACCTTCACCTTCTGG-39) or the PKR
ntisense nt 110 to 210 (59-CACCAGCCATTTCTTCT-
CC-39), and the plus anchor primer AP2 (Clontech).
9-RACE cDNA products were subcloned into the pBlue-
cript SK vector (Stratagene) for subsequent sequence
nalysis (Sanger et al., 1977). Nell maintenance and IFN treatment
Human amnion U cells were maintained in DMEM
upplemented with FBS (Hyclone) at 5% (vol/vol), 100
/ml penicillin, and 100 mg/ml streptomycin. Where indi-
ated, IFN treatment was 1000 IU/ml IFN-a (provided by
. Cantell, Helsinki, Finland) or IFN-aA/D (PBL Biochem-
cal Labs).
T-PCR analysis of the 59-UTR
Total RNA was isolated from human amnion U cells by
he modified guanidinium thiocyanate–phenol–chloro-
orm extraction method (Chomczynski and Sacchi, 1987)
TRI Reagent, Molecular Research Center) or by the urea
ysis–cesium chloride method (Kawakubo et al., 1994).
hen 3 mg of total RNA was transcribed using random
examer (pdN6, Pharmacia) and avian myeloblastosis
irus reverse transcriptase (Promega). For the detection
f the 59-region of the PKR mRNA, seminested PCR was
arried out. One fifth of the RT reaction was used as a
emplate for the subsequent PCR. PCR (Saiki et al., 1985)
as performed using native DNA Taq polymerase
Fisher) and conditions supplied by the manufacturer
Perkin–Elmer). First-round PCR was carried out using
he plus primer (59-GCGGCGGCGGCGGCGCAG-39) that
orresponds to the Pkr exon 1 sense sequence and the
UG 292 minus primer that corresponds to the antisense
equence at nt position 1303 to 1 282 (59-GTAATTC-
CCATGGATAATCC-39) within exon 11. Seminested PCR,
sing a fraction of the first-round PCR product as the
emplate, was performed using the same exon 1-specific
lus primer and the nested antisense AUG1 minus
rimer. PCR products were subcloned into the pBlue-
cript vector (Stratagene) for subsequent sequence anal-
sis by the Sanger sequencing method.
Nase protection analysis of the Pkr 59-UTR
A 406-bp human PKR cDNA fragment extending from
xon 1 (nt 2435) through the HindIII site within exon 2 (nt
30) was subcloned into pBluescript SK (Stratagene). A
RNA probe was generated in vitro using T3 RNA poly-
erase (Promega) according to the manufacturer’s in-
tructions using XhoI-linearized DNA template in a reac-
ion mixture containing 50 mCi of [a-32P]ATP. The 32P-
abeled cRNA product was treated with RNase-free
Nase (RQ1, Promega) before hybridization. Ten or 30 mg
f total RNA from U cells, either treated with IFN-a or left
ntreated, or from human placenta primary tissue (Clon-
ech) was dissolved in 30 ml of hybridization buffer (80%
ormamide, 40 mM piperazin-N,N9-bis(2-ethanesulfonic
cid), pH 6.4, 400 mM NaCl, 1 mM EDTA) containing a
0-fold excess of cRNA probe (2 3 105 cpm), heated at
0°C for 5 min, and incubated at 45°C for 12 h. Then 350
l of 10 mM Tris–HCl, pH 7.5, 5 mM EDTA, and 300 mM
aCl containing 40 mg of RNase A and 2 mg of RNase
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113SPLICE VARIANTS OF THE HUMAN PKR PROTEIN KINASE1/ml was added, and the reaction mixture was incu-
ated at 30°C for 40 min. After the addition of 50 mg of
roteinase K and 20 ml of 10% SDS, the mixture was
urther incubated for 15 min at 37°C and then subjected
o phenol extraction and ethanol precipitation with car-
ier tRNA. RNA samples were dissolved, denatured, and
ractionated in a 6% polyacrylamide-urea gel at 12 V/cm.
uantification of specific RNA–RNA complexes was per-
ormed with a Bio-Rad GS525 molecular PhosphorIm-
ger.
ybridization analysis of luciferase RNA
For measurement of the relative amount of luciferase
NA present in vivo within untreated and IFN-treated U
ells, total cytoplasmic RNA was prepared at 48 h after
ransfection and analyzed by the Northern dot-blot pro-
edure as previously described (White and Bancroft,
982; Atwater et al., 1986). Filters were probed with
uciferase-coding region-specific 32P-labeled XbaI–NcoI
NA fragment; quantification was performed with Phos-
horImager analysis.
onstruction of reporter gene plasmids
The pGL3-Control plasmid (Promega) containing the
uciferase gene (LUC) under the control of the SV40
romoter and enhancer was used for the construction of
eporter plasmids for transient transfection analysis of
uman PKR 59-UTR function. Reporter gene parent plas-
ids were prepared by inserting the indicated human
KR cDNA fragments corresponding to exon 1 and 2
soforms into the 59-UTR region according to standard
loning procedures (Sambrook et al., 1989) (see Fig. 4).
riefly, the three 59-UTR region splice-site variants of
uman PKR cDNA, exon 1–exon 2a, exon 1–exon 2b, and
xon 1–exon 2g, were subcloned into the pBluescript SK
lasmid. To obtain blunt-ended 59-UTR cDNA fragments,
he 59-UTR pBluescript SK constructions were digested
ith XhoI and HindIII and then treated with T4 DNA
olymerase. These blunted exon 1–exon 2 cDNA frag-
ents then were subcloned into the blunted HindIII site
mmediately upstream of the luciferase gene of pGL3-
ontrol plasmid. The pGL3-Enhancer plasmid, which
acks the SV40 promoter, was used as a negative control
lasmid. Three additional negative control constructions
ere prepared; they lacked the SV40 promoter but pos-
essed the three variant forms of exon 2 fused to exon 1
Fig. 4). All subcloning procedures were carried out ac-
ording to standard procedures (Sambrook et al., 1989).
tructures of plasmids were confirmed by restriction
nzyme analysis and by direct sequence analysis.
ransfection and reporter assays
For the transient expression analysis of 59-UTR func-
ion, human U cells (60-mm dishes) at a density of ;5 3
05 cells/plate were transfected by the DEAE-dextran–hloroquine phosphate transfection method (Luthman
nd Magnusson, 1983; Kuhen et al., 1998) using 5 mg of
he luciferase reporter gene construct and 2.5 mg of the
nternal reference plasmid pRSV2-b-gal. For comparative
urposes, the pGL3-Control (Promega) plasmid contain-
ng the SV40 promoter and enhancer and the pGL3-
nhancer containing only the SV40 enhancer were ana-
yzed. All DNA plasmids used in transfections were pu-
ified by cesium-chloride equilibrium centrifugation and
ere analyzed by agarose gel electrophoresis to verify
lasmid integrity. IFN-a treatment was carried out ;36 h
osttransfection. For analysis of luciferase activity, cells
ere harvested at 48 h after transfection according to the
eporter Lysis protocol (Promega) using 400 ml of re-
orter lysis buffer. The protein concentration of the ex-
racts was determined by the Bradford method (Bio-Rad).
uciferase activity was determined according to the
anufacturer’s recommendations (Promega) using 20 ml
f cell extract mixed with 100 ml of luciferase substrate
olution (Promega); activity measurements (20 s) were
uantified using an OPTOCOMP I luminometer (MGM
nstruments). b-Galactosidase activity was used to nor-
alize for transfection efficiency. Transfections were re-
eated three to five times in independent experiments to
ermit calculation of a mean value and standard devia-
ion.
aterials
Unless otherwise specified, all materials and reagents
ere as described previously (Thomis et al., 1992;
anaka and Samuel, 1994; Kuhen and Samuel, 1997).
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